动脉粥样硬化性肾动脉狭窄与细胞周期阻滞标志物升高相关:涉及肾血流减少和造影后缺氧
本研究在动脉粥样硬化性肾动脉狭窄(ARAS)患者(n=29)和原发性高血压健康对照(n=32)中检测肾静脉胰岛素样生长因子结合蛋白-7(IGFBP-7)和金属蛋白酶组织抑制因子-2(TIMP-2)水平,并分析其与肾血流减少及造影后缺氧的关系。结果显示ARAS患者基线IGFBP-7和TIMP-2水平高于原发性高血压对照组,基线IGFBP-7与造影后24小时缺氧及支架置入前皮质血流呈负相关,尽管存在造影剂注射和支架置入,高危ARAS患者中急性肾损伤罕见且不影响长期肾功能。
要点
- ARAS患者肾静脉IGFBP-7和TIMP-2水平较原发性高血压对照组升高。
- 基线IGFBP-7与造影后24小时缺氧及支架前皮质血流呈负相关。
- 尽管高危ARAS患者存在造影和支架置入,急性肾损伤罕见且不影响长期肾功能。
核心结论
- ARAS患者中IGFBP-7和TIMP-2水平升高,且与肾血流减少程度相关。
- 基线IGFBP-7水平升高与造影后缺氧的保护相关,符合「缺血预处理」现象。
- 尽管存在造影剂注射和支架置入,高危ARAS患者中急性肾损伤罕见且不影响长期肾功能。
研究设计与样本
- 研究纳入计划接受肾动脉支架置入的ARAS队列(n=29)和原发性高血压健康对照(n=32)。
- 采用多排CT在支架置入前和3个月后测量皮质和髓质肾血流。
- 所有患者在支架置入前和3个月后行BOLD成像,其中亚组(N=12)在CT/支架置入后24小时重复BOLD成像以检查造影后/术后缺氧水平。
主要发现
- ARAS组干预前IGFBP-7水平为18.5 ± 2.0 ng/mL,高于原发性高血压对照组的15.7 ± 1.5 ng/mL(P<0.0001)。
- ARAS组干预前TIMP-2水平为97.4 ± 23.1 ng/mL,高于原发性高血压对照组的62.7 ± 9.2 ng/mL(P<0.0001)。
- 基线IGFBP-7与造影剂注射后24小时发生的缺氧呈负相关(r = -0.73,P<0.0001)。
- 基线IGFBP-7与支架置入前皮质血流呈负相关(r = -0.59,P=0.004)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atherosclerotic renal artery stenosis (ARAS) reduces renal blood flow (RBF), ultimately leading to kidney hypoxia and inflammation. Insulin-like growth factor binding protein-7 (IGFBP-7) and tissue inhibitor of metalloproteinases-2 (TIMP-2) are biomarkers of cell cycle arrest, often increased in ischemic conditions and predictive of acute kidney injury (AKI). This study sought to examine the relationships between renal vein levels of IGFBP-7, TIMP-2, reductions in RBF and postcontrast hypoxia as measured by blood oxygen level-dependent (BOLD) magnetic resonance imaging. METHODS: Renal vein levels of IGFBP-7 and TIMP-2 were obtained in an ARAS cohort (n= 29) scheduled for renal artery stenting and essential hypertensive (EH) healthy controls (n = 32). Cortical and medullary RBFs were measured by multidetector computed tomography (CT) immediately before renal artery stenting and 3 months later. BOLD imaging was performed before and 3 months after stenting in all patients, and a subgroup (N = 12) underwent repeat BOLD imaging 24 h after CT/stenting to examine postcontrast/procedure levels of hypoxia. RESULTS: Preintervention IGFBP-7 and TIMP-2 levels were elevated in ARAS compared with EH (18.5 ± 2.0 versus 15.7 ± 1.5 and 97.4 ± 23.1 versus 62.7 ± 9.2 ng/mL, respectively; P< 0.0001); baseline IGFBP-7 correlated inversely with hypoxia developing 24 h after contrast injection (r = -0.73, P< 0.0001) and with prestent cortical blood flow (r = -0.59, P= 0.004). CONCLUSION: These data demonstrate elevated IGFBP-7 and TIMP-2 levels in ARAS as a function of the degree of reduced RBF. Elevated baseline IGFBP-7 levels were associated with protection against postimaging hypoxia, consistent with 'ischemic preconditioning'. Despite contrast injection and stenting, AKI in these high-risk ARAS subjects with elevated IGFBP-7/TIMP-2 was rare and did not affect long-term kidney function.
引用
- Saad A, Wang W, Herrmann SM, et al. Atherosclerotic renal artery stenosis is associated with elevated cell cycle arrest markers related to reduced renal blood flow and postcontrast hypoxia. Nephrol Dial Transplant. 2016. PMID: 27474749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。